Submission of Large Shareholding Report for Management Influence
Submitted a large shareholding report for the purpose of influencing management.
Special relationships include Aprogen Biologics Inc., Aptocrom Inc., Nexconix Inc., and Jade New Technology Fund No. 79.
Aprogen Biologics Inc.: Assets 586,993 million KRW, Liabilities 309,426 million KRW, Equity 277,567 million KRW, Capital 99,204 million KRW, Largest shareholder Aprogen Inc. 58.72%.
Aptocrom Inc.: Assets 21,370 million KRW, Liabilities 3,921 million KRW, Equity 17,449 million KRW, Capital 350 million KRW, Largest shareholder K Fortuna Investment Inc. 100%.
Jade New Technology Fund No. 79: Assets 67,599 million KRW, Liabilities 1,500 million KRW, Equity 66,099 million KRW, Representative Eastgate Investment Inc., Largest shareholder N2Tech Inc. 95.57%.
Financial information of Nexconix Inc. is included but specific figures are omitted.